US Broker Ratings

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Complex Landscape with a 24.66% Potential Upside

Avantor, Inc. (AVTR), a key player in the healthcare sector, stands at an intriguing crossroads for investors. With a market capitalization of $5.43 billion, Avantor is a significant entity within..

Natera, Inc. (NTRA) Stock Analysis: A 24.47% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector may find Natera, Inc. (NASDAQ: NTRA) an intriguing option, with a market cap of $29.6 billion and a robust portfolio in the diagnostics..

Henry Schein, Inc. (HSIC) Stock Analysis: Assessing a 22% Upside Potential in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a pivotal player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $8.48 billion, the company..

DaVita Inc. (DVA) Stock Analysis: Navigating a 0.04% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, is primarily focused on providing kidney dialysis services across the United States. With a market cap of $10 billion,..

Encompass Health Corporation (EHC) Stock Analysis: Unveiling a 31.95% Potential Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its impressive market performance and growth..

Bristol-Myers Squibb (BMY) Stock Analysis: Unpacking the 8.76% Potential Upside

For investors with a keen eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling opportunity. With a market capitalization of $118.87 billion, this biopharmaceutical giant continues..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Uncovering a 66.79% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, known for its dedication to developing therapies for rare and life-threatening conditions. With a market capitalization..

Fresenius Medical Care AG (FMS) Stock Analysis: Unlocking a 21.95% Potential Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Bad Homburg, Germany, the company specializes..

ResMed Inc. (RMD) Stock Analysis: Exploring a 31.99% Potential Upside in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, has positioned itself as a leader in the medical instruments and supplies industry. With a market capitalization of $29.87 billion,..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a Healthcare Giant with 11.1% Potential Upside

In the realm of healthcare giants, Johnson & Johnson (NYSE: JNJ) stands as a towering figure with a market capitalization of $546.9 billion. As one of the most recognized names..

Edwards Lifesciences Corporation (EW) Stock Analysis: 15.68% Potential Upside Beckons Investors

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, offers an intriguing investment opportunity with its robust portfolio of products designed to treat advanced cardiovascular diseases...

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: An Investor’s Guide to Potential 3.47% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, has garnered significant attention from investors seeking opportunities within the pharmaceutical industry. With a substantial market capitalization..

Illumina, Inc. (ILMN) Stock Analysis: Exploring its 33.82% Return on Equity

Illumina, Inc. (NASDAQ: ILMN), a leader in the Healthcare sector specializing in Diagnostics & Research, has been capturing investor attention with its impressive financial metrics and strategic collaborations. The company’s..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 28.98% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector might find Koninklijke Philips N.V. (NYSE: PHG) an intriguing prospect, especially given its significant potential upside of 28.98%. This Dutch multinational, with a..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 27% Potential Upside Amidst Robust Revenue Growth

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its compelling potential for stock appreciation...

Quest Diagnostics (DGX) Stock Analysis: Exploring a 15.81% Upside Potential for Investors

Quest Diagnostics Incorporated (NYSE: DGX), a titan in the healthcare sector specializing in diagnostics and research, is drawing investor attention with its substantial market presence and intriguing growth prospects. With..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 14.71% Potential Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the global healthcare sector, has captured investor attention with its strong market position in the specialty and generic drug manufacturing..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 33.72% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $10.19 billion, the..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a Potential 38% Upside

Tenet Healthcare Corporation (NYSE: THC) is making waves in the medical care facilities industry, offering a compelling investment opportunity for those eyeing the healthcare sector. With a market capitalization of..

The Cigna Group (CI) Stock Analysis: Potential 20.10% Upside Amid Strong Buy Ratings

For investors seeking a solid opportunity in the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling case, evidenced by a potential upside of 20.10% based on the average..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds